Comparison of 5‐year outcomes of paclitaxel‐eluting and endeavor zotarolimus‐eluting stents in New York

E-ISSN： 1522-726x|91|1|9-16

ISSN： 1522-1946

Source： CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol.91, Iss.1, 2018-01, pp. : 9-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of 2‐year clinical outcomes between zotarolimus‐, sirolimus‐, and paclitaxel‐eluting stents in real life clinical practice

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 83, Iss. 3, 2014-02 ,pp. : 349-359

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of 2‐year outcomes between zotarolimus‐eluting and everolimus‐eluting new‐generation cobalt–chromium alloy stents in real‐world diabetic patients

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 1, 2015-07 ,pp. : E11-E18

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of Bare-Metal and Sirolimus- or Paclitaxel-Eluting Stents for Aorto-Ostial Coronary Disease

Cardiology, Vol. 111, Iss. 4, 2008-05 ,pp. : 270-276

Karger

Access to resources Recommend Favorite

Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction

By Karjalainen Pasi Ylitalo Antti Niemela Matti Kervinen Kari Makikallio Timo Pietila Mikko Sia Jussi Tuomainen Petri Nyman Kai Airaksinen K. E. Juhani

Annals of Medicine, Vol. 41, Iss. 8, 2009-01 ,pp. : 599-607

Informa Healthcare

Access to resources Recommend Favorite

Comparisons of Everolimus and Paclitaxel‐Eluting Stents in Patients with Acute Myocardial Infarction

JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol. 28, Iss. 2, 2015-04 ,pp. : 147-156

John Wiley & Sons Inc

Access to resources Recommend Favorite